Analyst action: HealthSpring, Brookdale, Clarcor

UBS analyst Justin Lake has hiked his earnings estimates for Medicare insurer HealthSpring. But Lake, who has a 'buy' rating on the company, is sticking to his $52 price target, which still leaves the stock (Ticker: HS) about 40 percent of upside.

Morgan Keegan researcher Rob Mains says Brookdale Senior Living shares also can still climb more than 40 percent, but isn't in a hurry to jump in. In a note reiterating his 'outperform' rating, Mains says the stock (Ticker: BKD) may remain cheap "for a few months."

And over at Hilliard Lyons, analysts have launched coverage of Clarcor shares with a 'buy' rating and a $54 price target. That makes the firm the most optimistic on the Street about Clarcor (Ticker: CLC), which is changing hands at roughly $44 today.

Sep 9, 2011 12:55 PM

Clarcor adding to South Dakota plant

Multi-year plan will add 70 jobs
Sep 8, 2011 7:25 AM

Patent Patrol: 29 June 2011

In this week's batch of IP awarded to Tennessee residents and companies: Therapeutic light, a portable balloon-tying device, a biomass energy processing method, and more...
Jun 29, 2011 11:16 AM

Another big stock sale for Clarcor boss

Clarcor Chairman and CEO Norm Johnson on Monday sold almost $900,000 worth of shares in the Franklin-based company. The move came on the heels of a larger sale Friday. Combined, the two sets of transactions have trimmed Johnson's direct and indirect stake in Clarcor by about 5 percent.

Jun 22, 2011 9:21 AM

Clarcor CEO in seven-figure stock sale

Clarcor Chairman and CEO Norm Johnson late last week cashed in some of his chips, selling 30,000 shares of the Franklin-based company and grossing him more than $1.3 million. Johnson still controls more than $23 million of Clarcor shares, which have risen fivefold (Ticker: CLC) since he became CEO in March of 2000.

Jun 21, 2011 10:06 AM

Clarcor Q2 breezes by Street estimate

Overseas sales help lift operating margin to highest level since late 2008
Jun 15, 2011 7:17 AM

Clarcor algae JV ahead of plan — and the market

Ethanol Producer has an update on the Iowa bioreactor being built by a joint venture that includes Franklin-based Clarcor. The groundbreaking facility is looking to commercialize the production of algae by converting byproducts from ethanol production, but an end market for those algae hasn't yet materialized.

Therefore, GPRE and others have now taken on the role of product developers as well. Becker said they are currently developing markets to utilize the algae biomass as animal feed, as an ingredient for the pharmaceutical industry and for renewable fuels production. This includes biodiesel and ethanol. He noted that testing is currently under way to determine the viability of sending the algae directly to refineries to produce biofuel and they are also receiving promising results on tests to produce ethanol from the algae.

HT: Matt Largen

Apr 25, 2011 7:14 AM


Apr 12, 2011 7:18 AM
 | Subscriber Only Content

Clarcor GC books options gain

Richard Wolfson, general counsel of filtration and packaging company Clarcor, was plenty busy on the option front Wednesday. The 44-year-old, who has been with Franklin-based Clarcor since 2006, bought and sold tens of thousands of options and shares that resulted in a profit of about $240,000 and new share holdings worth another $400,000. Shares of Clarcor (Ticker: CLC) are up 5 percent so far in 2011 and almost 30 percent over the past year.

Apr 8, 2011 9:32 AM

Clarcor bumps board member retirement age

Looks like J. Marc Adam will get to stick around on Clarcor's board of directors for a little while longer. On Monday the filtration and packaging manufacturer's board unanimously voted to increase the mandatory retirement age for directors from 72 to 74, allowing Adam — who turned 72 prior to the company's annual meeting on Tuesday — to continue in his role through at least the end of the 2012 annual meeting.

Mar 24, 2011 12:01 PM